179 related articles for article (PubMed ID: 10555917)
1. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
Katayama Y; Kohriyama K; Matsui T
J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
[TBL] [Abstract][Full Text] [Related]
2. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
Shapiro M; Jimenez S; Werth VP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of myelopoiesis by gold salts and D-penicillamine.
Hamilton JA; Williams N
J Rheumatol; 1985 Oct; 12(5):892-6. PubMed ID: 3936930
[TBL] [Abstract][Full Text] [Related]
5. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
Derk CT; Jimenez SA
J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
[TBL] [Abstract][Full Text] [Related]
6. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
Jimenez SA; Sigal SH
J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
[TBL] [Abstract][Full Text] [Related]
7. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
Zvulunov A; Grunwald MH; Avinoach I; Halevy S
Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901
[No Abstract] [Full Text] [Related]
8. [A case of myasthenia gravis caused by D-penicillamine therapy].
Susa S; Akiba J; Kurimura M; Kurita K; Daimon M; Manaka H; Yamatani K; Kato T
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2513-5. PubMed ID: 9922674
[No Abstract] [Full Text] [Related]
9. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
Kahl LE; Medsger TA; Klein I
J Rheumatol; 1985 Oct; 12(5):990-1. PubMed ID: 4087275
[TBL] [Abstract][Full Text] [Related]
10. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
[TBL] [Abstract][Full Text] [Related]
11. Suppression of in vitro granulocytopoiesis by captopril and penicillamine.
Hammond WP; Miller JE; Starkebaum G; Zweerink HJ; Rosenthal AS; Dale DC
Exp Hematol; 1988 Sep; 16(8):674-80. PubMed ID: 2841147
[TBL] [Abstract][Full Text] [Related]
12. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
[TBL] [Abstract][Full Text] [Related]
13. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
14. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic use of d-penicillamine].
Bogdanikowa B
Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541
[No Abstract] [Full Text] [Related]
16. [Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl)].
Wozel G; Julius U
Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):85-93. PubMed ID: 6179735
[TBL] [Abstract][Full Text] [Related]
17. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.
Boehler A; Vogt P; Speich R; Weder W; Russi EW
Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954
[TBL] [Abstract][Full Text] [Related]
18. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus.
Nagao K; Tanikawa A; Yamamoto N; Amagai M
Clin Exp Dermatol; 2005 Jan; 30(1):43-5. PubMed ID: 15663502
[TBL] [Abstract][Full Text] [Related]
19. Progressive systemic sclerosis and penicillamine.
Rodnan GP
J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
[TBL] [Abstract][Full Text] [Related]
20. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
